Lindus Health has been shortlisted for the Fierce CRO Awards in the Outstanding Patient Recruitment and Retention Category
May 14, 2025
2
mins read
Lindus Health Named a 2025 Fierce CRO Award Finalist in the Outstanding Patient Recruitment and Retention Category
Anti-CRO Lindus Health Raises $55M in Series B Funding to Transform the Clinical Trial Landscape
1/22/25
3
mins
Learn more about how our Series B funding of $55 million supports our continued mission of bringing groundbreaking treatments to patients faster.
Lindus Health Releases "All-in-One Cardiovascular CRO" Offering for Clinical Trials Serving Cardiovascular Health
12/10/24
Introducing our latest CRO offering for the development of cardiovascular interventions.
Lindus Health Rolls Out “All-in-One Infectious Disease CRO” Bespoke to Clinical Trials for Infectious Disease Interventions
11/19/24
We're excited to introduce our latest CRO offering to the infectious disease market segment.
New Study from Lindus Health Finds Patients are More Likely to Join a Clinical Trial with Telehealth Care
11/12/24
Discover key findings from on clinical trial participation in our most recent consumer survey.
Lindus Health Introduces Its “All-in-One Women’s Health CRO” for Clinical Trials in the Women’s Health Space
10/29/24
Announcing our latest CRO and technology offering bespoke to the execution of women's health studies.
New Pharmanovia Study Results Reveal Chloral Hydrate Noticeably Improves Severe Insomnia Within Two Weeks
10/1/24
Pharmanovia's chloral hydrate elicited improvements in patients with severe insomnia. Learn more about our study together here.